Cargando…

α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils

Many neurodegenerative diseases including frontotemporal lobar degeneration (FTLD), Lewy body disease (LBD), multiple system atrophy (MSA), etc., show colocalized deposits of TDP-43 and α-synuclein (αS) aggregates. To understand whether these colocalizations are driven by specific molecular interact...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhakal, Shailendra, Mondal, Malay, Mirzazadeh, Azin, Banerjee, Siddhartha, Ghosh, Ayanjeet, Rangachari, Vijayaraghavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473755/
https://www.ncbi.nlm.nih.gov/pubmed/37662377
http://dx.doi.org/10.1101/2023.08.23.554502
_version_ 1785100330332061696
author Dhakal, Shailendra
Mondal, Malay
Mirzazadeh, Azin
Banerjee, Siddhartha
Ghosh, Ayanjeet
Rangachari, Vijayaraghavan
author_facet Dhakal, Shailendra
Mondal, Malay
Mirzazadeh, Azin
Banerjee, Siddhartha
Ghosh, Ayanjeet
Rangachari, Vijayaraghavan
author_sort Dhakal, Shailendra
collection PubMed
description Many neurodegenerative diseases including frontotemporal lobar degeneration (FTLD), Lewy body disease (LBD), multiple system atrophy (MSA), etc., show colocalized deposits of TDP-43 and α-synuclein (αS) aggregates. To understand whether these colocalizations are driven by specific molecular interactions between the two proteins, we previously showed that the prion-like C-terminal domain of TDP-43 (TDP-43PrLD) and αS synergistically interact to form neurotoxic heterotypic amyloids in homogeneous buffer conditions. However, it remains unclear whether and how αS modulates TDP-43 present within liquid droplets and biomolecular condensates called stress granules (SGs). Here, using cell culture and in vitro TDP-43PrLD – RNA liquid droplets as models along with microscopy, nanoscale spatially-resolved spectroscopy, and other biophysical analyses, we uncover the interactions of αS with phase-separated droplets. We learn that αS acts as a Pickering agent by forming clusters on the surface of TDP-43PrLD – RNA droplets and emulsifying them. The ‘hardening’ of the droplets that follow by αS aggregates on the periphery, nucleates the formation of heterotypic TDP-43PrLD amyloid fibrils with structures distinct from those derived from homogenous solutions. Together, these results reveal an intriguing property of αS as a Pickering agent in interacting with SGs and unmask the hitherto unknown role of αS in modulating TDP-43 proteinopathies.
format Online
Article
Text
id pubmed-10473755
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-104737552023-09-02 α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils Dhakal, Shailendra Mondal, Malay Mirzazadeh, Azin Banerjee, Siddhartha Ghosh, Ayanjeet Rangachari, Vijayaraghavan bioRxiv Article Many neurodegenerative diseases including frontotemporal lobar degeneration (FTLD), Lewy body disease (LBD), multiple system atrophy (MSA), etc., show colocalized deposits of TDP-43 and α-synuclein (αS) aggregates. To understand whether these colocalizations are driven by specific molecular interactions between the two proteins, we previously showed that the prion-like C-terminal domain of TDP-43 (TDP-43PrLD) and αS synergistically interact to form neurotoxic heterotypic amyloids in homogeneous buffer conditions. However, it remains unclear whether and how αS modulates TDP-43 present within liquid droplets and biomolecular condensates called stress granules (SGs). Here, using cell culture and in vitro TDP-43PrLD – RNA liquid droplets as models along with microscopy, nanoscale spatially-resolved spectroscopy, and other biophysical analyses, we uncover the interactions of αS with phase-separated droplets. We learn that αS acts as a Pickering agent by forming clusters on the surface of TDP-43PrLD – RNA droplets and emulsifying them. The ‘hardening’ of the droplets that follow by αS aggregates on the periphery, nucleates the formation of heterotypic TDP-43PrLD amyloid fibrils with structures distinct from those derived from homogenous solutions. Together, these results reveal an intriguing property of αS as a Pickering agent in interacting with SGs and unmask the hitherto unknown role of αS in modulating TDP-43 proteinopathies. Cold Spring Harbor Laboratory 2023-08-24 /pmc/articles/PMC10473755/ /pubmed/37662377 http://dx.doi.org/10.1101/2023.08.23.554502 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Dhakal, Shailendra
Mondal, Malay
Mirzazadeh, Azin
Banerjee, Siddhartha
Ghosh, Ayanjeet
Rangachari, Vijayaraghavan
α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils
title α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils
title_full α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils
title_fullStr α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils
title_full_unstemmed α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils
title_short α-Synuclein emulsifies TDP-43 prion-like domain – RNA liquid droplets to promote heterotypic amyloid fibrils
title_sort α-synuclein emulsifies tdp-43 prion-like domain – rna liquid droplets to promote heterotypic amyloid fibrils
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473755/
https://www.ncbi.nlm.nih.gov/pubmed/37662377
http://dx.doi.org/10.1101/2023.08.23.554502
work_keys_str_mv AT dhakalshailendra asynucleinemulsifiestdp43prionlikedomainrnaliquiddropletstopromoteheterotypicamyloidfibrils
AT mondalmalay asynucleinemulsifiestdp43prionlikedomainrnaliquiddropletstopromoteheterotypicamyloidfibrils
AT mirzazadehazin asynucleinemulsifiestdp43prionlikedomainrnaliquiddropletstopromoteheterotypicamyloidfibrils
AT banerjeesiddhartha asynucleinemulsifiestdp43prionlikedomainrnaliquiddropletstopromoteheterotypicamyloidfibrils
AT ghoshayanjeet asynucleinemulsifiestdp43prionlikedomainrnaliquiddropletstopromoteheterotypicamyloidfibrils
AT rangacharivijayaraghavan asynucleinemulsifiestdp43prionlikedomainrnaliquiddropletstopromoteheterotypicamyloidfibrils